The United States has officially lost measles-free status, reversing 26 years of public health gains as it faces its largest outbreak in more than 30 years.
The Pan American Health Organization (PAHO), the World Health Organization’s (WHO) Americas branch, on Tuesday declared measles endemic in the United States, Bolivia and Mexico, after determining that the same virus strain has been circulating continuously in each country for at least 12 months.
Recommended stories
list of 3 itemsend of list
An international panel of experts advising PAHO on the spread of measles and rubella “recommended that measles exclusion status be withdrawn,” said PAHO Director Dr. Gervase Barbosa, “and I accept this recommendation.”
Measles was declared eliminated in the United States in 2000.
Countries that lose measles-free status will be required to submit corrective action plans to PAHO in the coming weeks. PAHO has announced that it will submit recommendations to countries in the coming days.
PAHO’s announcement follows a review of epidemiological and laboratory evidence submitted by the Centers for Disease Control and Prevention (CDC).
In a joint statement released Tuesday, the CDC said it remains committed to containing the measles outbreak and restoring the country’s elimination status.
“Measles exclusion designation does not protect Americans. Vaccination does,” said CDC Director Erica Schwartz, adding that the agency remains committed to containing the outbreak.
The CDC announced it has provided approximately $100 million in additional funding to state and local health departments since August to strengthen vaccination efforts, surveillance, and outbreak response.
Approximately 7,700 measles cases have been recorded in the United States since the beginning of 2025, according to CDC statistics.
This is the highest number of infections in the country in more than 30 years. The rise in numbers comes as vaccine hesitancy has grown under Secretary of Health Robert F. Kennedy Jr., who has repeatedly questioned the safety of vaccines despite scientific evidence to the contrary.
Before taking office, President Kennedy claimed there were no “safe and effective” vaccines and promoted the discredited theory that vaccines cause autism.
To protect against the disease, children are commonly given the measles vaccine, known by the acronym MMR, in combination with the mumps and rubella vaccine.
But vaccination rates among U.S. preschoolers have fallen to about 92%, below the level experts say is needed to prevent outbreaks.
Kennedy, who served as secretary of health under President Donald Trump, has questioned the MMR vaccine’s ability to protect children.
He suggested that MMR’s effectiveness declines by about 4.5 percent per year and said it contained “fragments of aborted fetuses,” a claim experts rejected as false.
The CDC has confirmed six measles-related deaths this year, while state health officials in Pennsylvania, Wisconsin and New York have reported a total of 10 deaths, a discrepancy that has heightened tensions between federal and state health officials over how to classify and count measles deaths.
Measles is considered highly contagious, and the WHO estimates that by 2024, the virus will kill 95,000 people worldwide, most of them children.
Reversing decades of progress
Matt Ferrari, a professor of biology and director of the Center for Infectious Disease Dynamics at Penn State, believes the loss of measles elimination status in the United States could be a wake-up call for public health officials.
“This should be a humbling statement for the United States,” Ferrari told Al Jazeera.
For much of his career, Ferrari has researched strategies to control measles in countries around the world. Previously, the United States was seen as a model.
“This was an ambitious achievement that we will leverage to drive support for measles eradication programs around the world,” Ferrari said. “Right now we’re not playing to our strengths, so we have to look elsewhere for expertise.”
Edwin Asturias, a professor of pediatrics, infectious diseases and epidemiology at the University of Colorado, said the loss of status is a “stain” on the country’s public health program.
“Measles cases indicate problems with the vaccination program and other systems within the public health service,” he told Al Jazeera.
Asturias said the United States has the resources and experience to prevent a resurgence of the virus, noting that it has successfully eradicated measles transmission in the region for more than a quarter of a century.
He said about 40% of current measles cases in the United States are in adults 20 and older, highlighting the need to scale up vaccination efforts.
To reach these people, Asturias explained, vaccines need to be made available in workplaces, places of worship and other communities, rather than relying solely on pediatricians and family doctors.
Losing exclusion status also has implications beyond U.S. borders, as measles can be spread through international travel and migration.
“The United States is no longer a safe place from measles,” Asturias told Al Jazeera. “If you’re a regular person walking around with your kids, you need to know now that measles has come to this country and is here to stay unless something else is done.”
This risk is especially concerning for unvaccinated people and those who cannot receive vaccines, such as people with weakened immune systems or those undergoing cancer treatment.

What happens next?
Public health experts say the announcement should prompt a broader vaccination effort.
While some don’t expect PAHO’s announcement to prompt major changes in federal policy, some hope it will prompt action by state and local health officials.
Ferrari argued that the U.S. should look to countries with experience in containing measles outbreaks, such as India, where community health workers visit homes to identify children who may not have been vaccinated or whose families may be reluctant to vaccinate.
He also suggested states may need to reconsider their vaccination strategies, including whether to give early first or second doses to protect young children in areas where measles is endemic.
In the United States, children are routinely given two doses of the MMR vaccine. The first dose is usually given to children between 12 and 15 months of age, and the second dose is given at preschool age, between 4 and 6 years of age. Two doses are approximately 97% effective in preventing measles.
In countries where measles is more prevalent, the second dose of MMR is often given between 18 and 24 months of age.
In June, Pennsylvania began recommending an additional early dose, known as a “zero dose,” for infants 6 months and older in areas where measles transmission continues. Ferrari said this is a perfect example of how states can adapt their approach locally.
But broader changes in the federal government’s response remain unlikely.
CDC Director Schwartz said last week that even if the U.S. loses eradication status, the agency “will continue to do exactly the same thing” on measles control.
For Asturias, the federal government’s response so far has raised concerns about whether the country has the public health leadership needed to stop the spread of infection.
“It’s hard to imagine this happening,” he said. “But at the same time, it’s predictable when you don’t have the experts to run the public health system.”
